High Point Advisor Group LLC Vertex Pharmaceuticals Inc Transaction History
High Point Advisor Group LLC
- $1.67 Billion
- Q3 2024
A detailed history of High Point Advisor Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 3,485 shares of VRTX stock, worth $1.57 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,485
Previous 4,428
21.3%
Holding current value
$1.57 Million
Previous $2.08 Million
21.93%
% of portfolio
0.1%
Previous 0.12%
Shares
15 transactions
Others Institutions Holding VRTX
# of Institutions
1,723Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.1 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.4 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.6 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.32 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.05 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...